We help scientists and innovators to find solutions using genome engineering technologies.
genetic diseases targeted by genome editing tools like CRISPR
gene-editing clinical trials are currently active.
gene-editing trials show promising early-stage results.
Patients Diagnosed with Rare Diseases Currently Benefit from Genomic Therapies
Executive Director
Scientific Expert
Policy Expert
Legal Expert
Program manager
treasurer
Communication lead
Communication lead
